Bluejay Diagnostics (BJDX) Treasury Shares (2022 - 2025)

Bluejay Diagnostics has disclosed Treasury Shares across 4 years of filings, most recently posting $1.0 for Q1 2025.

• Treasury Shares for Q1 2025 came in at $1.0, down 99.9% year-over-year; the trailing twelve-month figure through Mar 2025 was $1.0 (down 99.9% YoY), and the FY2024 annual result was $1.0, down 95.0% from the prior year.
• Treasury Shares came in at $1.0 for Q1 2025 at Bluejay Diagnostics, roughly flat from $1.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $197500.0 in Q1 2023 to a low of $1.0 in Q4 2024.
• The 4-year median for Treasury Shares is $2000.0 (2022), against an average of $33158.0.
• Across the five-year window, Treasury Shares plunged 89.5% in 2023 and slumped 99.9% in 2025, its largest moves.
• Bluejay Diagnostics' Treasury Shares stood at $3000.0 in 2022, then slumped by 99.33% to $20.0 in 2023, then tumbled by 95.0% to $1.0 in 2024, then changed by 0.0% to $1.0 in 2025.
• The last three Treasury Shares figures came in at $1.0 (Q1 2025), $1.0 (Q4 2024), and $62.0 (Q3 2024), per Business Quant data.